Appearance of Epstein-Barr virus-associated antigens in infected Raji cells.
D000042:Absorption; D000941:Antigens / Q000302:isolation & purification*; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D002478:Cells, Cultured / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D005260:Female; D005455:Fluorescent Antibody Technique; D006564:Herpesviridae / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology; D007106:Immune Sera; D008214:Lymphocytes; D009500:Neutralization Tests; D010649:Phenylalanine / Q000378:metabolism; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis
D000941:Antigens; D007106:Immune Sera; D014764:Viral Proteins; D003561:Cytarabine; D014316:Tritium; D010649:Phenylalanine; D011691:Puromycin; D012313:RNA; D004247:DNA; D007065:Idoxuridine; D013936:Thymidine; D014529:Uridine